Filter
360
Text search:
guidelines
for
pharmacovigilance
Featured
Recommendations
49
New Publications
119
Language
Document type
No document type
198
Guidelines
62
Studies & Reports
41
Strategic & Response Plan
22
Manuals
18
Training Material
6
Fact sheets
6
Situation Updates
4
Resource Platforms
1
Infographics
1
Online Courses
1
Countries / Regions
Kenya
22
Uganda
14
Ghana
13
India
13
Western and Central Europe
13
Nigeria
12
South Africa
11
Ethiopia
10
Namibia
10
Eastern Europe
10
Nepal
9
Global
9
Sierra Leone
7
Zambia
7
Tanzania
7
Rwanda
7
Malawi
7
Cambodia
5
South–East Asia Region
5
Latin America and the Carribbean
5
Liberia
4
Senegal
4
Bangladesh
4
Zimbabwe
3
Botswana
3
Lesotho
3
West and Central Africa
3
Africa
3
Russia
3
Haiti
2
Philippines
2
Indonesia
2
Mozambique
2
Sudan
2
Eswatini/ Swaziland
2
Brazil
2
Myanmar / Burma
2
East and Southern Africa
2
Middle East and North Africa
2
Eastern Europe and Central Asia
2
Asia
2
Congo, Democratic Republic of
1
Morocco
1
Cameroon
1
Pakistan
1
Jordan
1
Afghanistan
1
Lebanon
1
Syria
1
Thailand
1
Gambia
1
Benin
1
Argentina
1
Ukraine
1
Libya
1
Sri Lanka
1
Yemen
1
Western Pacific Region
1
Paraguay
1
Bhutan
1
Southern Africa
1
Laos
1
Georgia
1
Maldives
1
Authors & Publishers
Publication Years
Category
Countries
183
Clinical Guidelines
51
Public Health
11
Capacity Building
7
Pharmacy & Technologies
7
Women & Child Health
6
Key Resources
2
Toolboxes
TB
48
Pharmacy
44
AMR
31
COVID-19
21
HIV
20
NTDs
13
NCDs
4
Rapid Response
3
Refugee
2
Caregiver
2
Planetary Health
2
Ebola
1
Cholera
1
Polio
1
Specific Hazards
1
This Indicator-Based Pharmacovigilance Assessment Tool (IPAT) was developed as a comprehensive performance metric for pharmacovigilance and medicin
...
WHO Pharmacovigilance indicators: a practical manual for the assessment of pharmacovigilance systems
This manual provides a practical method for determining the pharmacovigilance indices. It is designed to be simple and can be understood by any worker in
...
Made under Section 5 (c) of the Tanzania Food, Drugs and Cosmetics Act, 2003 | Second Edition
WHO Guidelines for malaria
recommended
25 Nov 2022
The WHO Guidelines for malaria bring together the Organization’s most up-to-date recommendations for malaria in one user-friendly a
...
6th edition
These guidelines for the National Pharmacovigilance and Medicine Information System in Rwanda have been developed to ensure that safe, efficacious
...
The Guidelines for the Diagnosis, Treatment and Prevention of Leprosy provide state-of-the-art knowledge and evidence on leprosy diagnosis, treatment and prevention based on a public health approach
...
In preparing this paper, the Pharmacovigilance Group of the Pan American Health Organization’s Pan American Network for Drug Regulatory Harmonization (PANDRH) adopted the perspective of PAHO/WHO,
...
Accessed November, 2017
The Zimbabwe National Pharmacovigilance Policy Handbook, 2nd Edition updates the November 2013 version to indicate the Zimbabwe National Pharmacovigilance (PV) Centre’s compliance with the WHO
...
The manufacturing process is one of the key steps where quality control is required to ensure quality of medicinal products, including herbal medicines. Good manufacturing practices (GMP) is one of the most important tools for this measure.
The conditionality of this recommendation is largely driven by the current higher unit cost of pyrethroid-PBO ITNs compared
to pyrethroid-only LLINs and therefore the uncertainty of their cost-effectiveness. Furthermore, as PBO is less wash-resistant
than pyrethroids, its bioavailability declines
...
STGs are designed to assist health care professionals in making decisions about appropriate, effective patient care. However, health managers often have trouble setting and meeting the high standards required of modern, developed health care systems. With stakeholders expressing concern over issues
...